Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Jun;161(6):447-68. doi: 10.1016/j.trsl.2013.02.008. Epub 2013 Mar 20.

PMID:
23523954
[PubMed - indexed for MEDLINE]
2.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
[PubMed - indexed for MEDLINE]
3.

Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma.

Paul AG, Sharma-Walia N, Chandran B.

PLoS One. 2011;6(9):e24379. doi: 10.1371/journal.pone.0024379. Epub 2011 Sep 30.

PMID:
21980345
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.

Sadagopan S, Valiya Veettil M, Paudel N, Bottero V, Chandran B.

J Virol. 2011 Mar;85(6):2666-85. doi: 10.1128/JVI.01532-10. Epub 2011 Jan 5.

PMID:
21209106
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.

Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C.

Br J Cancer. 2006 May 22;94(10):1504-9.

PMID:
16705315
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.

Jiang Y, Xu D, Zhao Y, Zhang L.

PLoS One. 2008 Feb 6;3(2):e1569. doi: 10.1371/journal.pone.0001569.

PMID:
18253508
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y.

J Virol. 1997 Jan;71(1):314-24.

PMID:
8985352
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.

Spadavecchia S, Gonzalez-Lopez O, Carroll KD, Palmeri D, Lukac DM.

J Virol. 2010 Oct;84(20):10488-500. doi: 10.1128/JVI.00894-10. Epub 2010 Aug 4.

PMID:
20686042
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].

Katano H.

Uirusu. 2010 Dec;60(2):237-45. Review. Japanese.

PMID:
21488336
[PubMed - indexed for MEDLINE]
Free Article
13.

COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.

Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K, Guillaudeux T.

Clin Cancer Res. 2014 May 15;20(10):2663-73. doi: 10.1158/1078-0432.CCR-13-2305. Epub 2014 Mar 17.

PMID:
24637636
[PubMed - indexed for MEDLINE]
14.

Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.

Lacoste V, Judde JG, Bestett G, Cadranel J, Antoine M, Valensi F, Delabesse E, Macintyre E, Gessain A.

Leuk Lymphoma. 2000 Jul;38(3-4):401-9.

PMID:
10830748
[PubMed - indexed for MEDLINE]
16.

Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.

Blood. 1997 Aug 1;90(3):1186-91.

PMID:
9242551
[PubMed - indexed for MEDLINE]
Free Article
17.

Gamma-herpesvirus neoplasia: a growing role for COX-2.

Shelby BD, Nelson A, Morris C.

Microsc Res Tech. 2005 Nov;68(3-4):120-9. Review.

PMID:
16276519
[PubMed - indexed for MEDLINE]
18.

Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.

Wu W, Rochford R, Toomey L, Harrington W Jr, Feuer G.

Leuk Res. 2005 May;29(5):545-55. Epub 2005 Jan 19.

PMID:
15755507
[PubMed - indexed for MEDLINE]
19.

Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.

Xu D, Coleman T, Zhang J, Fagot A, Kotalik C, Zhao L, Trivedi P, Jones C, Zhang L.

J Virol. 2007 Jun;81(11):6068-78. Epub 2007 Mar 21.

PMID:
17376914
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.

Lai IY, Farrell PJ, Kellam P.

J Gen Virol. 2011 Feb;92(Pt 2):421-31. doi: 10.1099/vir.0.025494-0. Epub 2010 Oct 27.

PMID:
20980528
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk